Tags

Type your tag names separated by a space and hit enter

A Theoretically Based Mobile App to Increase Pre-Exposure Prophylaxis Uptake Among Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial.
JMIR Res Protoc. 2020 Feb 21; 9(2):e16231.JR

Abstract

BACKGROUND

HealthMindr is a mobile phone HIV prevention app for men who have sex with men (MSM). In a previous pilot study, HealthMindr was found to be acceptable among users and to demonstrate preliminary effectiveness for increasing pre-exposure prophylaxis (PrEP) uptake among MSM. PrEP is a highly effective HIV prevention intervention; however, uptake remains low.

OBJECTIVE

The aim of this study will be to assess the efficacy of a mobile app for increasing PrEP uptake among MSM in the southern United States.

METHODS

In this randomized controlled trial, we will assess the efficacy of HealthMindr for increasing PrEP uptake among MSM in the following three southern US cities: Atlanta, Georgia; Jackson, Mississippi; and Washington, DC. In total, 657 men will be recruited and randomized to intervention and control arms in a 2:1 ratio. Participants in the intervention arm will receive access to the full HealthMindr app, with information and resources about PrEP (eg, frequently asked questions, risk assessment tool, and PrEP provider locator), other HIV prevention information, ability to order free HIV/sexually transmitted infection test kits, and additional resources related to substance use and mental health. Participants in the control arm will use the HealthMindr app but will only have access to the study timeline and a message center to communicate with study staff. Participants will complete quarterly surveys to assess self-reported PrEP uptake over 12 months of follow-up. Self-reported PrEP uptake will be verified by dried blood spot testing and/or uploading a photograph of a PrEP prescription.

RESULTS

Participant recruitment began in January 2020.

CONCLUSIONS

This trial will determine whether the HealthMindr app can increase PrEP uptake among MSM in the southern United States.

TRIAL REGISTRATION

ClinicalTrials.gov NCT03763942; https://clinicaltrials.gov/ct2/show/NCT03763942.

INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)

PRR1-10.2196/16231.

Authors+Show Affiliations

Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States.Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA, United States.Department of Systems, Populations and Leadership, School of Nursing, University of Michigan, Ann Arbor, MI, United States.Division of Allergy & Infectious Diseases, School of Medicine, University of Washington, Seattle, WA, United States.Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington, DC, United States.Department of Population Health Science, John D Bower School of Population Health, University of Mississippi Medical Center, Jackson, MS, United States.Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States.Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA, United States.Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32130178

Citation

Jones, Jeb, et al. "A Theoretically Based Mobile App to Increase Pre-Exposure Prophylaxis Uptake Among Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial." JMIR Research Protocols, vol. 9, no. 2, 2020, pp. e16231.
Jones J, Dominguez K, Stephenson R, et al. A Theoretically Based Mobile App to Increase Pre-Exposure Prophylaxis Uptake Among Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020;9(2):e16231.
Jones, J., Dominguez, K., Stephenson, R., Stekler, J. D., Castel, A. D., Mena, L. A., Jenness, S. M., Siegler, A. J., & Sullivan, P. S. (2020). A Theoretically Based Mobile App to Increase Pre-Exposure Prophylaxis Uptake Among Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial. JMIR Research Protocols, 9(2), e16231. https://doi.org/10.2196/16231
Jones J, et al. A Theoretically Based Mobile App to Increase Pre-Exposure Prophylaxis Uptake Among Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020 Feb 21;9(2):e16231. PubMed PMID: 32130178.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A Theoretically Based Mobile App to Increase Pre-Exposure Prophylaxis Uptake Among Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial. AU - Jones,Jeb, AU - Dominguez,Karen, AU - Stephenson,Rob, AU - Stekler,Joanne D, AU - Castel,Amanda D, AU - Mena,Leandro A, AU - Jenness,Samuel M, AU - Siegler,Aaron J, AU - Sullivan,Patrick S, Y1 - 2020/02/21/ PY - 2019/09/12/received PY - 2019/12/15/accepted PY - 2019/11/26/revised PY - 2020/3/5/entrez PY - 2020/3/5/pubmed PY - 2020/3/5/medline KW - HIV KW - electronic health KW - men who have sex with men KW - mobile health KW - pre-exposure prophylaxis SP - e16231 EP - e16231 JF - JMIR research protocols JO - JMIR Res Protoc VL - 9 IS - 2 N2 - BACKGROUND: HealthMindr is a mobile phone HIV prevention app for men who have sex with men (MSM). In a previous pilot study, HealthMindr was found to be acceptable among users and to demonstrate preliminary effectiveness for increasing pre-exposure prophylaxis (PrEP) uptake among MSM. PrEP is a highly effective HIV prevention intervention; however, uptake remains low. OBJECTIVE: The aim of this study will be to assess the efficacy of a mobile app for increasing PrEP uptake among MSM in the southern United States. METHODS: In this randomized controlled trial, we will assess the efficacy of HealthMindr for increasing PrEP uptake among MSM in the following three southern US cities: Atlanta, Georgia; Jackson, Mississippi; and Washington, DC. In total, 657 men will be recruited and randomized to intervention and control arms in a 2:1 ratio. Participants in the intervention arm will receive access to the full HealthMindr app, with information and resources about PrEP (eg, frequently asked questions, risk assessment tool, and PrEP provider locator), other HIV prevention information, ability to order free HIV/sexually transmitted infection test kits, and additional resources related to substance use and mental health. Participants in the control arm will use the HealthMindr app but will only have access to the study timeline and a message center to communicate with study staff. Participants will complete quarterly surveys to assess self-reported PrEP uptake over 12 months of follow-up. Self-reported PrEP uptake will be verified by dried blood spot testing and/or uploading a photograph of a PrEP prescription. RESULTS: Participant recruitment began in January 2020. CONCLUSIONS: This trial will determine whether the HealthMindr app can increase PrEP uptake among MSM in the southern United States. TRIAL REGISTRATION: ClinicalTrials.gov NCT03763942; https://clinicaltrials.gov/ct2/show/NCT03763942. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/16231. SN - 1929-0748 UR - https://www.unboundmedicine.com/medline/citation/32130178/A_Theoretically_Based_Mobile_App_to_Increase_Pre_Exposure_Prophylaxis_Uptake_Among_Men_Who_Have_Sex_With_Men:_Protocol_for_a_Randomized_Controlled_Trial_ L2 - https://www.researchprotocols.org/2020/2/e16231/ DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.